GlassScriptPhysician profile
Mary E Manuel
NPI 1851388599
$5,092.55
in general payments reported to CMS, 2019-2025
10 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $161 · 2022: $331 · 2023: $4,127 · 2024: $240 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,913 · Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,912.52 |
| Food and Beverage | $688.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $3,912.52 | 2023 | Nexplanon |
| Pfizer INC. | $294.57 | 2022-2025 | |
| Incyte Corporation | $241.72 | 2021-2025 | Opzelura, Opzelura |
| Novartis Pharmaceuticals Corporation | $240.88 | 2021-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $149.75 | 2021-2023 | Siliq |
| Leo Pharma INC. | $104.67 | 2025 | Anzupgo |
| Regeneron Healthcare Solutions, INC. | $47.65 | 2022 | |
| Sun Pharmaceutical Industries INC. | $47.65 | 2022 | |
| Galderma Laboratories, L.P. | $28.48 | 2021 | |
| Masimo Corporation | $24.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Manuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.